JPWO2022230925A1 - - Google Patents

Info

Publication number
JPWO2022230925A1
JPWO2022230925A1 JP2023517589A JP2023517589A JPWO2022230925A1 JP WO2022230925 A1 JPWO2022230925 A1 JP WO2022230925A1 JP 2023517589 A JP2023517589 A JP 2023517589A JP 2023517589 A JP2023517589 A JP 2023517589A JP WO2022230925 A1 JPWO2022230925 A1 JP WO2022230925A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023517589A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022230925A1 publication Critical patent/JPWO2022230925A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023517589A 2021-04-28 2022-04-27 Pending JPWO2022230925A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021075797 2021-04-28
PCT/JP2022/019043 WO2022230925A1 (ja) 2021-04-28 2022-04-27 膿皮症改善剤

Publications (1)

Publication Number Publication Date
JPWO2022230925A1 true JPWO2022230925A1 (ja) 2022-11-03

Family

ID=83848520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023517589A Pending JPWO2022230925A1 (ja) 2021-04-28 2022-04-27

Country Status (2)

Country Link
JP (1) JPWO2022230925A1 (ja)
WO (1) WO2022230925A1 (ja)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138125A (ja) * 1993-11-19 1995-05-30 Shiseido Co Ltd 皮膚外用剤
EP1604645B1 (en) * 1997-11-07 2009-09-23 Medion Research Laboratories Inc. Therapeutic and cosmetic use of Viscous compositions containing carbon dioxide
JP2000302673A (ja) * 1999-04-22 2000-10-31 Shiseido Co Ltd アトピー性皮膚炎用皮膚外用剤
JP4011787B2 (ja) * 1999-04-22 2007-11-21 株式会社資生堂 選択的抗菌組成物
JP2000319187A (ja) * 1999-05-06 2000-11-21 Medion Research Laboratories Inc 二酸化炭素経皮・経粘膜吸収用組成物
JP4347973B2 (ja) * 1999-12-20 2009-10-21 希能 澤口 口腔用又は外用薬組成物
TWI327474B (en) * 2001-04-06 2010-07-21 Neochemir Inc Kit for preparation of carbon dioxide agent for external use.
TWI330531B (en) * 2003-08-19 2010-09-21 Neochemir Inc A composition for preparing carbon dioxide external gel and the carbon dioxide external gel
JP4392748B2 (ja) * 2004-02-16 2010-01-06 株式会社資生堂 皮膚外用組成物
WO2006072832A1 (en) * 2005-01-07 2006-07-13 Pfizer Products Inc. Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
CN101746906A (zh) * 2008-12-03 2010-06-23 五邑大学 一种含重金属离子电镀废水的处理方法
JP2013100267A (ja) * 2011-10-11 2013-05-23 Daiichi Sankyo Healthcare Co Ltd ビタミン類を含有する抗炎症のための皮膚外用剤組成物
US20150164831A1 (en) * 2012-03-30 2015-06-18 Takeda Pharmaceuticals U.S.A., Inc. Colchicine formulations; methods of making; and methods of use thereof
FR2994386B1 (fr) * 2012-08-07 2016-06-24 Thorel Jean-Noel Inhibition de l'adhesion de micro-organismes pathogenes par un ester de saccharose et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee
US20170027881A1 (en) * 2015-07-30 2017-02-02 Neil A. Shah Composition and related methods for treatment of pilosebaceous diseases
EP3644945B1 (en) * 2017-06-27 2023-06-07 Rottapharm SPA Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
CN109010294A (zh) * 2018-08-27 2018-12-18 邓倩 一种头孢妥仑匹酯片剂的生产工艺
GB201911071D0 (en) * 2019-08-02 2019-09-18 Meda Pharma S P A Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment
US20230320962A1 (en) * 2020-09-08 2023-10-12 Apr Applied Pharma Research Sa Dermal compositions replicating the vernix caseosa
CN112402391A (zh) * 2020-12-16 2021-02-26 湖北凌晟药业有限公司 一种头孢卡品酯颗粒剂及其制备方法

Also Published As

Publication number Publication date
WO2022230925A1 (ja) 2022-11-03

Similar Documents

Publication Publication Date Title
BR112021014123A2 (ja)
JPWO2022138866A1 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
JPWO2022230925A1 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016176A2 (ja)
BR102021016200A2 (ja)
BR102021015566A2 (ja)
BR102021015450A8 (ja)
BR102021015220A2 (ja)
BR102021015247A2 (ja)
BR102021014056A2 (ja)
BR102021014044A2 (ja)
BR102021013929A2 (ja)
BR102021012571A2 (ja)
BR102021012230A2 (ja)
BR102021012107A2 (ja)